C-arm manufacturer OEC Medical Systems reported strong third-quarter (end-September) results this month. The company posted revenues of $47.9 million, an increase of 23% over $39 million in sales for the same period last year. The quarter’s net
C-arm manufacturer OEC Medical Systems reported strong third-quarter (end-September) results this month. The company posted revenues of $47.9 million, an increase of 23% over $39 million in sales for the same period last year. The quarters net income climbed 25%, from $3.4 million to $4.3 million.
Executives with the Salt Lake City firm attributed the strong product demand to the increase in minimally invasive procedures, as well as increasing use by healthcare delivery networks of outpatient procedures.
In other OEC news, the company announced Oct. 16 that Dallas-based supply chain management company Novation awarded OEC a three-year contract, making OEC Novations sole-source supplier of mobile C-arms. The deal is estimated at approximately $30 million annually. It includes OECs Mini 6600 C-arm and its full-size mobile units Series 9600, 7600, and 7700. The OEC award is Novations first capital equipment contract as a new entity, according to OEC.
Can Radiomics and Autoencoders Enhance Real-Time Ultrasound Detection of Breast Cancer?
September 10th 2024Developed with breast ultrasound data from nearly 1,200 women, a model with mixed radiomic and autoencoder features had a 90 percent AUC for diagnosing breast cancer, according to new research.
Researchers Show Higher Breast Cancer Upstaging Rate with 18F-FAPI PET/CT
September 9th 2024The imaging agent 18F-FAPI PET/CT demonstrated greater than a 45 percent higher sensitivity rate in comparison to 18F-FDG PET/CT for the detection of axillary and extraaxillary regional lymph node metastases, according to a lesion-based analysis from a recent study.
Study Assesses Lung CT-Based AI Models for Predicting Interstitial Lung Abnormality
September 6th 2024A machine-learning-based model demonstrated an 87 percent area under the curve and a 90 percent specificity rate for predicting interstitial lung abnormality on CT scans, according to new research.